Posts by Tracey G. Simon, MD, MPH
-
Medical Grand Rounds: Updates in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
In a Medical Grand Rounds presentation, Kathleen Corey, MD, MPH, MMSc, and Tracey Simon, MD, MPH, of the Division of Gastroenterology at Massachusetts General Hospital, presented on the assessment of non-alcoholic fatty liver disease and the prevention of hepatocellular carcinoma.
-
Cardiovascular Disease Risk Elevated in Children and Young Adults With NAFLD
Tracey G. Simon, MD, MPH, and colleagues have provided the first nationwide estimate of cardiovascular risk in children and young adults with nonalcoholic fatty liver disease, finding the disease doubles the risk of incident major adverse cardiovascular events and triples the risk of incident arrhythmia.
-
Red Meat Consumption Increases Risk of Nonalcoholic Fatty Liver Disease in Women
In a large prospective cohort of U.S. women, Massachusetts General Hospital researchers found that a higher intake of red meat contributed to a significant, dose-dependent increased risk of developing nonalcoholic fatty liver disease, and this association was largely mediated by obesity.
-
Physical Activity Reduces Chronic Liver Disease Mortality Risk
Massachusetts General Hospital researchers have demonstrated for the first time that exercise is an independent determinant of mortality from cirrhosis and its complications.
-
Epoxyeicosatrienoic Acid May Be a Biomarker for Nonalcoholic Steatohepatitis
Massachusetts General Hospital researchers have identified a non-invasive means to identify which patients with nonalcoholic fatty liver disease are at high risk of nonalcoholic steatohepatitis.
-
Daily Aspirin Use Tied to Lower Risk of Fibrosis Progression in Nonalcoholic Fatty Liver Disease
Long-term data from a prospective cohort of patients with nonalcoholic fatty liver disease, who reported their aspirin use regularly, provides evidence of hepatoprotective effects of daily aspirin.
Biography
Tracey Simon, MD, MPH, is a hepatologist in the Division of Gastroenterology, and an Instructor of Medicine at Harvard Medical School. Dr. Simon treats all forms of liver disease, and specializes in the diagnosis and management of non-alcoholic fatty liver disease. Her research focuses on developing strategies to prevent cirrhosis, and reduce the risk for hepatocellular carcinoma.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.